Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplant vs Standard of Care for CGD
NCT00023192Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2001
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic hematopoietic stem cells in chronic granulomatous disease (CGD), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2001; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on NCT00023192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023192.